The Regents of the University of California, San Francisco (UCSF) has been awarded a $31,110,405.00 Cooperative Agreement by the Department of the Interior's Interior Business Center under the Advanced Research Projects Agency for Health (ARPA-H) program (CFDA 93.384). This 5-year award, effective April 1, 2024, supports the development of a "Programmable Platform for Targeting Therapies to the Brain" to advance cell therapies for neuroinflammation and neurodegeneration. The ARPA-H program funds high-risk, high-reward biomedical and health research projects with transformative potential. Through this award, UCSF will leverage its expertise as a leading academic medical center to deliver innovative solutions targeting neurological diseases.
Generated 12/31/24, 10:59 AM